Advanced search
Publication Cover
Modern Rheumatology Volume 19, 2009 - Issue 4
Journal homepage
52
Views
7
CrossRef citations to date
0
Altmetric
Original Article

A comparative study of the effects of bucillamine and salazosulfapyridine in the treatment of rheumatoid arthritis

Mikio NakajimaDepartment of Orthopedic Surgery, Osaka Medical College, 2-7 Daigaku-machi, Takatsuki, Osaka 569-8686, JapanCorrespondence[email protected]
,
Naoki UedaDepartment of Orthopedic Surgery, Osaka Medical College, 2-7 Daigaku-machi, Takatsuki, Osaka 569-8686, Japan
,
Hidetsugu OharaDepartment of Orthopedic Surgery, Osaka Medical College, 2-7 Daigaku-machi, Takatsuki, Osaka 569-8686, Japan
,
Muneaki AbeDepartment of Orthopedic Surgery, Shiroyama Hospital, 2-8-1 Habikino, Habikino, Osaka 583-0872, Japan
&
Mitsuo KinoshitaDepartment of Orthopedic Surgery, Osaka Medical College, 2-7 Daigaku-machi, Takatsuki, Osaka 569-8686, Japan
Pages 384-389 | Received 21 Nov 2008, Accepted 16 Mar 2009, Published online: 02 Jan 2014

References

  • Bores M. Understanding the window of opportunity concept in early rheumatoid arthritis. Arthritis Rheum. 2003;48:1771–4.
  • Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum. 2008;59:762–84.
  • Ministry of Health, Labour and Welfare Study Group. Manual for diagnosis and therapeutic guidelines on evidence-based medicine (in Japanese). 1st ed. Tokyo: Japan Rheumatism Foundation; 2004. p. 90–1.
  • Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–24.
  • Yamasaki K. Diagnostic criteria for early rheumatoid arthritis of the Ministry of Health and Welfare in Japan (in Japanese). Jpn Med J. 1988;3360:43–7.
  • Yamamoto S, Kashiwazaki S, Nobunaga T. Study on Japan Rheumatism Association diagnostic criteria for early rheumatoid arthritis-2. Proposed diagnostic criteria for early rheumatoid arthritis (in Japanese). Ryumachi. 1994;34: 1013–8.
  • Shiokawa Y, Abe S, Warabi H, Abe S, Kageyama T, Kosaka S, et al. Clinical evaluation of 5A96 on rheumatoid arthritis (in Japanese). Jpn J Inflamm. 1985;5:333–43.
  • Shiokawa Y, Ogawa N, Abe S, Kosaka S, Honma M, Akizuki M, et al. Clinical evaluation of 5A96 for RA (in Japanese). Igaku no Ayumi. 1985;135:1116–33.
  • Kashiwazaki S, Shiokawa Y. Bucillamine: a new immunomod-ulator. Int J Immunother. 1987;3:106–11.
  • Goto M, Yamada T, Nishioka K. The long-term effects of buc-illaminein the treatment of early-stage rheumatoid arthritis. Int J Immunother. 1992;8:147–51.
  • Nagashima M, Shu G, Yamamoto K, Yamahatsu S, Yoshino S. The ability of disease modifying antirheumatic drugs to induce and maintain improvement in patients with rheumatoid arthritis. Epidemiology of DMARDs treatment in Japan. Clin Exp Rheu-matol. 2005;23:27–35.
  • Iwatani M, Inoue E, Nakamura T, Nakajima A, Hara M, Tomatsu T, et al. Efficacy profile of bucillamine in rheumatoid arthritis patients in a large observational cohort study, IORRA. Mod Rheumatol. 2006;16:376–80.
  • Kim SY, Lee IH, Bae SC, Yoo DH. Preliminary trial of the efficacy of bucillamine in Korean patients with rheumatoid arthritis. Clin Drug Investig. 1995;9:284–90.
  • Kim HA, Song YW. A comparison between bucillamine and fi-penicillamine in the treatment of rheumatoid arthritis. Rheu-matol Int. 1997;17:5–9.
  • Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet. 2001;358:903–11.
  • Nuver-Zwart IH, van Riel PL, van de Putte LB, Gribnau FW. A double blind comparative study of sulfasalazine and hydroxy-chloroquine in rheumatoid arthritis: evidence of an earlier effect of sulfasalazine. Ann Rheum Dis. 1989;48:389–95.
  • Porter D, Madhok R, Hunter JA, Capell HA. Prospective trial comparing the use of sulphasalazine and auranofin as second line drugs in patients with rheumatoid arthritis. Ann Rheum Dis. 1992;51:461–4.
  • Neumann VC, Grindulis KA, Hubball S, McConkey B, Wright V. Comparison between penicillamine and sulphasalazine in rheu-matoid arthritis: Leeds-Birmingham trial. Br Med J. 1983;287: 1099–102.
  • Gadangi P, Longaker M, Naime D, Levin RI, Recht PA, Mntesinos MC, et al. The anti-inflammatory mechanism of sulfasalazine is related to adenosine release at inflamed sites. J Immunol. 1996;156:1937–41.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.